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The so-called “golden hour” of trauma resuscitation has been applied to a number of disease conditions in the
intensive care unit (ICU) setting. For example, the “golden hour” as applied to the treatment of critically children and
adults with severe sepsis and septic shock is based upon early recognition, early administration of antibiotics, and early
reversal of the shock state. However, several clinical studies published over the last decade have called into question
this time-honored approach and suggest that overly aggressive fluid resuscitation may cause more harm than good.
Perhaps we are finally leaving the “Golden Age” of the “golden hour” and entering a new age in which we are able to
use a more personalized approach to fluid management for patients with severe sepsis/septic shock.For nearly two decades, if not longer, the treatment of
critically ill children with severe sepsis and septic shock
has rested on three fundamental tenets—early recogni-
tion, early administration of antibiotics, and early rever-
sal of the shock state with aggressive fluid resuscitation
and administration of vasoactive medications. Recently,
these fundamental tenets of sepsis treatment have been
called into question. Investigators from the Alberta
Sepsis Network prospectively enrolled 79 critically ill
children with severe sepsis/septic shock admitted to two
pediatric intensive care units (PICUs) over a 2-year
period. Aggressive fluid resuscitation in the early stages
of treatment was independently associated with longer
PICU length of stay and days on mechanical ventilation
[1]. While the Alberta Sepsis Network investigators were
careful to not to overstate their conclusions, the results
of this study further call into question what was once
considered part and parcel of the management of critic-
ally ill children with severe sepsis and septic shock.
A vast body of literature strongly supports the para-
digm that early initiation of therapy in the intensive care
unit (ICU) setting, regardless of the clinical condition, is
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patients has been applied to a number of clinical condi-
tions, including acute coronary syndrome, stroke, and
severe sepsis/septic shock. Early recognition and treat-
ment of these and similar conditions is believed to arrest
the complex chain of events occurring at the molecular
and cellular levels that lead to irreversible organ dys-
function and eventual death. The concept of a “golden
hour” in patients with severe sepsis/septic shock was
supported by early studies performed in both critically ill
children [2–4] and adults [5]. The landmark early, goal-
directed therapy in sepsis trial [5], in particular, sup-
ported the concept of a “golden hour” as one of the first
prospective, randomized, clinical trials in sepsis to show
a significant reduction in overall mortality. With the
subsequent work of the Surviving Sepsis Campaign [6],
it seemed that the field of critical care medicine had
truly entered a “golden age” of the “golden hour” of sep-
sis treatment.
Several small, retrospective and prospective, observa-
tional studies performed in critically ill children have
demonstrated an association between fluid overload and
poor outcomes. While the initial studies involved critic-
ally ill children requiring renal replacement therapy, sub-
sequent studies showed that fluid overload was associated
with worse outcomes even in critically ill children who
were not receiving renal replacement therapy [7, 8]. The
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ial design, showed that a restrictive fluid management
strategy was superior to a liberal fluid management strat-
egy in 1000 critically ill adults with acute lung injury [9].
The mean cumulative fluid balance during the first 7 days
of treatment was −136 mL in the restrictive fluid manage-
ment group versus 6992 mL in the liberal fluid manage-
ment group. While 60-day mortality was not different
between the two groups, the number of ventilator-free
days and ICU-free days was higher in the restrictive fluid
management group, with no significant differences in the
incidence or prevalence of shock or use of dialysis in the
first 60 days. Over 3000 African children (Uganda, Kenya,
and Tanzania) presenting with severe febrile illness and
clinical evidence of impaired perfusion were randomized
to receive boluses of 0.9 % saline (20–40 mL/kg), 5 % al-
bumin (20–40 mL/kg), or no bolus at initial presentation.
Somewhat surprisingly, children randomized to the con-
trol group (no bolus) had lower mortality at 48 hours and
4 weeks after treatment. Notably, patients with severe
hypotension were randomized to either the saline or albu-
min group only [10]. These significant differences in mor-
tality between the two bolus groups versus no bolus
control group occurred in children regardless of initial
presentation among three pre-defined clinical presenta-
tions (shock, respiratory, or neurologic disease), and the
cause of death in the bolus groups was more often attrib-
uted to cardiovascular collapse rather than fluid overload
[11]. Finally, in the last 2 years, several prospective, ran-
domized, multicenter clinical trials have failed to demon-
strate any improvement in outcomes with protocolized,
early goal-directed therapy of critically ill patients with se-
vere sepsis/septic shock [12].
With all of the aforementioned studies in mind, the re-
sults provided by the Alberta Sepsis Network investiga-
tors provide additional evidence that overly aggressive
fluid resuscitation in critically ill children with severe
sepsis/septic shock is not only unlikely to be helpful, but
also is probably harmful. We simply do not have the
ability to adequately discriminate between patients who
are likely to benefit from fluid resuscitation versus those
who are likely to be harmed from fluid resuscitation,
given that the relevant pathophysiology of shock occurs
at the molecular, cellular, and organ-specific levels. To
this end, a panel of biomarkers has been used to stratify
the risk of mortality for critically ill children with severe
sepsis/septic shock, and a recently published study
showed that a positive fluid balance after ICU admission
is associated with worse outcomes for those children
with a low-risk of mortality, but not in those children
with moderate-to-high risk of mortality [13].
Rather than abandoning a time-honored therapeutic
strategy, perhaps we should first strive to find better
clinical markers of fluid-responsiveness. Clearly, thetraditional markers used to date (heart rate, urine out-
put, blood pressure, capillary refill, central venous pres-
sure, pulmonary artery occlusion pressure, etc.) are not
sufficient for the task. We need better therapeutic end-
points of resuscitation that are readily available at the
bedside. Until that time, it seems prudent to recommend
a careful, deliberate approach to fluid resuscitation [14].
Critically ill children with low blood pressure should be
appropriately resuscitated with fluid bolus therapy (20–
40 mL/kg, repeated as necessary until blood pressure
normalizes). However, beyond the initial phase of resus-
citation (and in the absence of severe hypotension), fluids
should be carefully titrated in small, incremental doses
(“fluid challenge”), perhaps as small as 3–5 mL/kg in chil-
dren, based upon the currently available therapeutic end-
points [14, 15]. Additional fluids should be withheld in
the absence of clinically significant improvement in
these endpoints. Perhaps we are leaving the “golden
age” of the “golden hour” and entering a new age in
which we are able to use a more personalized approach
to the treatment of severe sepsis/septic shock.
Abbreviations
ICU: Intensive care unit; PICU: Pediatric intensive care unit.
Competing interests
The author declares that he has no competing interests.
References
1. van Paridon BM, Sheppard C, Guerra GG, Joffe AR. Timing of antibiotics,
volume, and vasoactive infusions in children with sepsis admitted to intensive
care. Crit Care. 2015;19:293.
2. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric
septic shock. JAMA. 1991;266:1242–5.
3. Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, et al.
Early reversal of pediatric-neonatal septic shock by community physicians is
associated with improved outcome. Pediatrics. 2003;112:793–9.
4. de Oliveira CF, de Oliveira DS, Gottschald AF, Moura JD, Costa GA, Ventura
AC, et al. ACCM/PALS haemodynamic support guidelines for paediatric
septic shock: an outcomes comparison with and without monitoring of
central venous oxygen saturation. Intensive Care Med. 2008;34:1065–75.
5. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early
goal-directed therapy in the treatment of severe sepsis and septic shock. N
Engl J Med. 2001;345:1368–77.
6. Marshall JC, Dellinger RP, Levy M. The Surviving Sepsis Campaign: a history
and a perspective. Surg Infect (Larchmt). 2010;11:275–81.
7. Raghunathan K, Shaw AD, Bagshaw SM. Fluids are drugs: type, dose, and
toxicity. Curr Opin Crit Care. 2013;19:290–8.
8. Goldstein SL. Fluid management and acute kidney injury. J Intensive Care
Med. 2014;29:183–9.
9. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome
(ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR,
Thompson BT, Hayden D, et al. Comparison of two fluid-management
strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.
10. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al.
Mortality after fluid bolus in African children with severe infection. N Engl J
Med. 2011;364:2483–95.
11. Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, et al.
Exploring mechanisms of excess mortality with early fluid resuscitation:
insights from the FEAST trial. BMC Med. 2013;11:68.
12. Gupta RG, Hartigan SM, Kashiouris MG, Sessler CN, Bearman GM. Early goal-
directed resuscitation of patients with septic shock: current evidence and
future directions. Crit Care. 2015;19:286.
Wheeler Critical Care  (2015) 19:447 Page 3 of 313. Abulebda K, Cvijanovich NZ, Thomas NJ, Allen GL, Anas N, Bigham MT, et al.
Post-ICU admission fluid balance and pediatric septic shock outcomes: a
risk-stratified analysis. Crit Care Med. 2014;42:397–403.
14. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, et al. Four
phases of intravenous fluid therapy: a conceptual model. Br J Anaesth. 2014;
113:740–7.
15. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med. 2006;34:1333–7.
